Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (Q44774860)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 February 2004
edit
Language Label Description Also known as
English
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
scientific article published on 23 February 2004

    Statements

    Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (English)
    J Atzpodien
    H Kirchner
    L Bergmann
    H Heynemann
    P Fornara
    S A Loening
    S C Müller
    H Bodenstein
    B Metzner
    U Rebmann
    R Oberneder
    M Siebels
    T Wandert
    T Puchberger
    Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
    23 February 2004
    1188-1194

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit